Hepatitis A

• CLINICAL_TRIALS trial_result · 2010-08-26
  Clinical Trial Update: Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule [Phase 3]

  Phase 3 trial assessing long-term immune persistence of GSK's combined Hepatitis A & B vaccine given at 0, 1, 6 months; study completed with…

• CLINICAL_TRIALS trial_result · 2010-07-05
  Clinical Trial Update: Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™ [Phase 4]

  Phase 4 trial updating antibody persistence and immune memory after adolescence vaccination with Twinrix, focusing on Hepatitis A and B.

• CLINICAL_TRIALS trial_result · 2010-04-01
  Clinical Trial Update: Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children [Phase 3]

  A Phase 3 study evaluating immunogenicity and safety of Hepatitis A vaccine given together with MMR and Varicella vaccines in children.

• CLINICAL_TRIALS trial_result · 2010-03-08
  Clinical Trial Update: Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule [Phase 4]

  A Phase 4 study by GlaxoSmithKline evaluated how long immune responses persist after a two-dose (0 and 12 months) schedule of their inactiva…

• CLINICAL_TRIALS trial_result · 2010-03-04
  Clinical Trial Update: Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule [Phase 4]

  This Phase 4 study assesses the long-term immune persistence of GlaxoSmithKline's inactivated hepatitis A vaccine given on a 0 and 6 month s…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2010-01-11
  Clinical Trial Update: A Study of 2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069) [Phase 3]

  Phase 3 trial evaluating two doses of VAQTA in healthy children aged 12 to 23 months. Results have been posted.

• CLINICAL_TRIALS trial_result · 2009-12-03
  Clinical Trial Update: Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination [Phase 4]

  Phase 4 trial evaluating immune memory to Twinrix or comparator after a challenge dose 4 years post-vaccination, with results previously pos…

• CLINICAL_TRIALS trial_result · 2009-08-14
  Clinical Trial Update: Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years [Phase 3]

  Phase 3 long-term follow-up study comparing two formulations of a combined hepatitis A/B vaccine in adolescents (ages 12-15); results coveri…

• CLINICAL_TRIALS trial_result · 2009-08-03
  Clinical Trial Update: Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067) [Phase 4]

  Phase 4 trial evaluating concomitant administration of a Hepatitis A vaccine with MMRV and Prevnar 7 in healthy 12-month-old children; resul…

• CLINICAL_TRIALS trial_result · 2009-07-24
  Clinical Trial Update: Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months [Phase 3]

  Phase 3 trial update on the immunogenicity and safety of Havrix co-administered with diphtheria-tetanus-pertussis and Haemophilus b vaccines…

• CLINICAL_TRIALS trial_result · 2009-06-23
  Clinical Trial Update: Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery [Phase 2, Phase 3]

  The document reports on ongoing Phase 2 and Phase 3 trials evaluating serological responses to Varicella and Hepatitis A vaccines delivered …

• CLINICAL_TRIALS trial_result · 2009-06-04
  Clinical Trial Update: Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared [Phase 3]

  A Phase 3 long-term follow-up study comparing two dosing schedules of the combined hepatitis A and B vaccine; results completed with posted …

• CLINICAL_TRIALS trial_result · 2008-11-20
  Clinical Trial Update: Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) [Phase 4]

  A Phase 4 safety study evaluating Merck's Hepatitis A inactivated vaccine and Measles, Mumps, Rubella and Varicella Live vaccine (ProQuad) h…

• CLINICAL_TRIALS trial_result · 2008-10-16
  Clinical Trial Update: Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean Population

  This completed clinical trial evaluated the safety of GlaxoSmithKline's Hepatitis A vaccine in a Korean population.

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: A Controlled Prospective Study of Transfusion-Associated Hepatitis

  A controlled prospective study investigating transfusion-associated hepatitis has completed.

• CLINICAL_TRIALS trial_result · 2007-11-01
  Clinical Trial Update: Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2 [Phase 3]

  A Phase 3 clinical trial is evaluating Hepatitis A vaccination in HIV-infected individuals with an adjuvant Interleukin-2. The current statu…